Nevada 2025 Regular Session

Nevada Assembly Bill AB304

Introduced
2/27/25  
Refer
2/27/25  
Report Pass
4/16/25  
Refer
4/17/25  
Report Pass
5/28/25  
Engrossed
5/31/25  
Refer
5/31/25  
Report Pass
6/1/25  
Failed
6/3/25  
Enrolled
6/6/25  
Chaptered
6/11/25  

Caption

Establishing certain notification and reporting requirements concerning pilot programs that research transcranial magnetic stimulation or electromagnetic brain pulse treatment. (BDR S-865)

Impact

The implications of AB304 on state laws include the establishment of clear guidelines for the conduct of research related to TMS and electromagnetic brain pulse treatment. By mandating pre-implementation notifications and quarterly reports, the bill seeks to ensure that research activities adhere to ethical standards and are properly monitored. The requirement for final reports upon completion of the pilot programs will contribute to a repository of knowledge regarding these advanced treatment methodologies, potentially influencing future healthcare practices and policies.

Summary

Assembly Bill 304 (AB304) establishes notification and reporting requirements for practitioners or entities conducting pilot programs that research transcranial magnetic stimulation (TMS) or electromagnetic brain pulse treatment. The bill aims to create a framework for oversight by requiring these practitioners to notify the Director of the Legislative Counsel Bureau before starting any research and to provide ongoing reports throughout the duration of the pilot program. This structured approach is intended to enhance transparency and accountability in healthcare research within the state.

Sentiment

The sentiment surrounding AB304 appears generally positive, with support from lawmakers and professionals who see the need for regulated research practices in the emerging field of mental health treatments. Proponents argue that the bill will help safeguard the interests of participants in clinical studies while promoting innovative therapies. However, there may be some concern regarding the bureaucratic process that such requirements could impose on researchers, possibly affecting the pace of advancements in mental health treatment.

Contention

Notable points of contention regarding AB304 may include discussions about the balance between regulation and innovation. While proponents advocate for oversight to protect research subjects and ensure ethical standards, critics may argue that excessive regulatory requirements could deter practitioners from exploring new treatment options. Furthermore, clarity regarding the collaborative efforts with institutions of higher learning and the implications of funding sources, such as grants, could form additional areas of debate as the bill is considered.

Companion Bills

No companion bills found.

Previously Filed As

NV H152

Access to Transcranial Magnetic Stimulation

NV H3968

Electromagnetic Pulse Protection

NV H5542

Electromagnetic Pulse

NV H4818

Electromagnetic Pulse Protection

NV SB751

Veterans and Former First Responders Research Pilot Program.

NV S2254

Concerns notification requirements for certain utility assistance programs; repeals law establishing notification requirements for public and local utilities during coronavirus 2019 pandemic.

NV SB537

Research Facilities and Testing Facilities That Use Animals - Adoption and Reporting Requirements

NV SB422

Research Facilities and Testing Facilities That Use Animals - Adoption and Reporting Requirements

NV HB665

Research Facilities and Testing Facilities That Use Animals - Adoption and Reporting Requirements

NV HB1296

Mental health; pilot program to support clinical research of certain veterans and first responders suffering from certain conditions; provide

Similar Bills

IN SB0180

Various health care matters.

CA AB2442

Peptides.

TX SB268

Relating to the procedure for certain complaints against health care practitioners.

OR HB3817

Relating to ibogaine.

CA AB1739

Crimes: sexual exploitation: clergy.

MS SB2438

MS Medical Cannabis Act; allow cannabis use by certain persons when conventional treatment options have proven ineffective.

MS SB2748

Mississippi Medical Cannabis Act; revise provisions related to.

OH SB301

Regards noncompete clauses in health care employment contracts